FAQ

Is the ReWalk™ suitable for me?

In its current configuration and functionality, the ReWalk™ is suitable for lower-limb mobility impaired adults who have functioning hands, arms and shoulders, as well as the ability to stand (healthy skeleton and cardio-vascular system). An approval from a physician is required.

When will the ReWalk™ be released for the market?

ReWalk™-I, the institutional version, is currently available for purchase by rehabilitation hospitals and centers in Europe and in the USA.

ReWalk™-P, the personal version, will be available for purchase by private users in the end of 2011.

Where can I use the ReWalk™ until the personal version is available?

You may contact you local rehabilitation center and advice them to purchase ReWalk-I, which will serve you and other paraplegics for training and practicing walking.

What will be the price of the ReWalk™?

Please contact us for prices.

Will the ReWalk™ be reimbursable by health-insurance?

Based on our surveys and on precedents, we strongly believe that the ReWalk™ will be partially or fully reimbursable, depending on the region (country).

Is Argo interested in strategic partnerships?

Argo is seeking strategic partners who will be able to effectively provide marketing / sales, training, technical support and any other customer support function. Companies which manufacture and market / sale orthotic equipment (e.g. prosthetics) or mobility equipment (e.g. wheelchairs) or organizations which operate orthopedic and / or neurologic rehabilitation centers or workshops are our prime targets for strategic partnerships. Companies / organizations which have at least nationwide (countrywide) presence in sales and / or service will be preferential candidates.

Can I become a ReWalk™ distributor?

Argo welcomes contacts with companies who are well established in the rehabilitation sector in their respective countries.

Can I invest in Argo?

Argo is currently in the midst of a capital investment recruitment round and we will gladly consider private or institutional investments of a minimum of $1,000,000 in return for equity.

Please contact us if you have an interest in receiving additional information on an investment opportunity.

Can I participate in the ReWalk™ clinical trials?

Persons who show interest in participating in the clinical trials should periodically check on our website for specific Information regarding relevant sites.

Do I have an advantage in signing-up early on for possible purchase of the ReWalk™?

Argo does not manage a "waiting list" for the ReWalk™. However, we welcome contact details of prospective institutions and end-users of the ReWalk™, in order to update them on relevant events and dates, such as expected commercial availability dates and details of the points of sale in different global regions.

How do I contact Argo?

The best way to reach us is by filling out the contact form in 'Contact Us' page or at http://argomedtec.com/contact.asp#form.
We will do our best to respond to all inquiries promptly. However, due to the current intense media exposure of the ReWalk™, Argo is “flooded” with inquiries which might cause some delays in our response, for which we apologize in advance.
In any case, all inquiries are saved in our database for future communication.